PCM
MED icon

Palouse Capital Management’s Medifast MED Stock Holding History

Palouse Capital Management’s Portfolio MED Stock Details MED Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q1 		– Sell
-2,497
Closed -$274K – 87
2019
Q4 		$274K Sell
2,497
-587
-19% -$56.8K 0.1% 66
2019
Q3 		$320K Buy
+3,084
New +$331K 0.12% 69
2014
Q2 		– Sell
-10,460
Closed -$304K – 122
2014
Q1 		$304K Sell
10,460
-750
-7% -$20.1K 0.11% 104
2013
Q4 		$293K Sell
11,210
-15
-0.1% -$384 0.11% 106
2013
Q3 		$302K Sell
11,225
-75
-0.7% -$2.01K 0.12% 101
2013
Q2 		$291K Buy
+11,300
New +$297K 0.12% 94

Other funds holding MED

BlackRock
BlackRock New York $5.7T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
EC
Engaged Capital Newport Beach, California $303M AUM 2.09% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
MVP
Miller Value Partners Sarasota, Florida $383M AUM 38.57% 1-Year Est. Return
CS
Credit Suisse Zurich, Switzerland $104B AUM 34.76% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
RHJA
Rice Hall James & Associates San Diego, California $1.8B AUM 36.16% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
NCM
Nantahala Capital Management New Canaan, Connecticut $1.6B AUM 121.58% 1-Year Est. Return